Equities

Enfusion Inc

ENFN:NYQ

Enfusion Inc

Actions
TechnologyTechnology
  • Price (USD)9.50
  • Today's Change-0.05 / -0.52%
  • Shares traded238.32k
  • 1 Year change+0.74%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Enfusion Inc grew revenues 16.09% from 150.35m to 174.54m while net income improved from a loss of 7.65m to a gain of 6.03m.
Gross margin67.15%
Net profit margin2.38%
Operating margin3.48%
Return on assets3.92%
Return on equity5.54%
Return on investment6.28%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Enfusion Inc fell by 26.94m. However, the company earned 25.63m from its operations for a Cash Flow Margin of 14.69%. In addition the company used 9.67m on investing activities and also paid 43.08m in financing cash flows.
Cash flow per share0.1404
Price/Cash flow per share73.68
Book value per share0.5443
Tangible book value per share0.5443
More ▼

Balance sheet in USDView more

Enfusion Inc uses little or no debt in its capital structure.
Current ratio3.62
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 170.92%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-62.30
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.